Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
Journal of Clinical Medicine|October 29, 2020
Health-Related Quality of Life in Patients with Chronic Myeloid Leukemia Treated with First- Versus Second-Generation Tyrosine Kinase InhibitorsAdi Shacham Abulafia, Sivan Shemesh, Lena Rosenmann, et al.Leukemia & Lymphoma|May 31, 2022
Repeat biopsy in relapsed or refractory diffuse large B cell lymphoma: a nationwide survey and retrospective studyTamar Berger, Karyn Revital Geiger, Moshe Yeshurun, et al.Acta Haematologica|July 31, 2022
Prevalence and Clinical Characteristics of Paraproteinemia Associated with Chronic Myeloid LeukemiaTamar Berger, Adi Shacham Abulafia, Shai Shimony, et al.Leukemia & Lymphoma|July 21, 2021
Late onset neutropenia after rituximab and obinutuzumab treatment - characteristics of a class-effect toxicityShai Shimony, Einat Bar-Sever, Tamar Berger, et al.Leukemia & Lymphoma|September 6, 2022
Infectious complications and long-term outcomes in patients with diffuse large B-Cell lymphoma and diabetes mellitusOren Pasvolsky, Tamar Berger, Karyn Revital Geiger, et al.EJNMMI Research|September 14, 2022
Effect of steroid treatment on the diagnostic yield of baseline <sup>18</sup>f-fluorodeoxyglucose positron emission tomography in aggressive B cell lymphomaKaryn Revital Geiger, Oren Pasvolsky, Tamar Berger, et al.Infectious Diseases and Therapy|March 4, 2021
Diarrheal Morbidity During Hematopoietic Cell Transplantation: The Diagnostic Yield of Stool CulturesTamar Berger, Odil Giladi, Dafna Yahav, et al.Journal of Thrombosis and Thrombolysis|February 1, 2021
Anticoagulation in patients with atrial fibrillation, thrombocytopenia and hematological malignancyNir Livneh, Dionne Braeken, Genady Drozdinsky, et al.Hematological Oncology|November 2, 2019
Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational studyShai Shimony, Netanel Horowitz, Elena Ribakovsky, et al.Cell Reports|December 18, 2015
Preventing the Androgen Receptor N/C Interaction Delays Disease Onset in a Mouse Model of SBMALori Zboray, Anna Pluciennik, Dana Curtis, et al.Pageof 4